Human milk mucin 1 and mucin 4 inhibit salmonella enterica serovar typhimurium invasion of human intestinal epithelial cells in vitro

Journal of Nutrition

Volumn 142, Issue 8, 2012, Pages 1504-1509

  Liu, Bo ^a,b   Yu, Zhuoteng ^a,b   Chen, Ceng ^a,b   Kling, David E ^b   Newburg, David S ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; GLYCAN DERIVATIVE; MUCIN 1; MUCIN 4;

ARTICLE; CELL INTERACTION; CELL INVASION; CELL LABELING; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION PREVENTION; INTERNALIZATION; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; MILK; MOLECULAR WEIGHT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN ISOLATION; SALMONELLA ENTERICA; SALMONELLOSIS; SEROTYPE;

CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; MILK, HUMAN; MUCIN-1; MUCIN-4; SALMONELLA TYPHIMURIUM;

SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 84866274618     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.155614     Document Type: Article

References (35)

1. Newburg DS. Bioactive components of human milk: evolution, efficiency, and protection. Adv Exp Med Biol. 2001;501:3-10.
2. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr. 2005;25:37-58.
3. Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S, Marcus R, Cieslak PR, Deneen VC, Tauxe RV. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004;38 Suppl 3:S127-34.
4. Jones TF, Ingram LA, Fullerton KE, Marcus R, Anderson BJ, McCarthy PV, Vugia D, Shiferaw B, Haubert N, Wedel S, et al. A case-control study of the epidemiology of sporadic Salmonella infection in infants. Pediatrics. 2006;118:2380-7.
5. Savino F, Roana J, Mandras N, Tarasco V, Locatelli E, Tullio V. Faecal microbiota in breast-fed infants after antibiotic therapy. Acta Paediatr. 2011;100:75-8.
6. Bessler HC, de Oliveira IR, Giugliano LG. Human milk glycoproteins inhibit the adherence of Salmonella typhimurium to HeLa cells. Microbiol Immunol. 2006;50:877-82.
7. Yolken RH, Peterson JA, Vonderfecht SL, Fouts ET, Midthun K, Newburg DS. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest. 1992;90:1984-91.
8. Parker P, Sando L, Pearson R, Kongsuwan K, Tellam RL, Smith S. Bovine Muc1 inhibits binding of enteric bacteria to Caco-2 cells. Glycoconj J. 2010;27:89-97.
9. Vimal DB, Khullar M, Gupta S, Ganguly NK. Intestinal mucins: the binding sites for Salmonella typhimurium. Mol Cell Biochem. 2000;204:107-17.
10. Schroten H, Hanisch FG, Plogmann R, Hacker J, Uhlenbruck G, Nobis-Bosch R, Wahn V. Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction. Infect Immun. 1992;60:2893-9.
11. Ruvoën-Clouet N, Mas E, Marionneau S, Guillon P, Lombardo D, Le Pendu J. Bile-salt-stimulated lipase and mucins from milk of 'secretor' mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochem J. 2006;393:627-34.
12. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. Mucins in the mucosal barrier to infection. Mucosal Immunol. 2008;1:183-97.
13. Baggesen DL, Wegener HC. Phage types of Salmonella enterica ssp. enterica serovar typhimurium isolated from production animals and humans in Denmark. Acta Vet Scand. 1994;35:349-54.
14. Li Q, Cherayil BJ. Role of Toll-like receptor 4 in macrophage activation and tolerance during Salmonella enterica serovar Typhimurium infection. Infect Immun. 2003;71:4873-82.
15. Hara-Kaonga B, Pistole TG. A dual fluorescence flow cytometric analysis of bacterial adherence to mammalian host cells. J Microbiol Methods. 2007;69:37-43.
16. Parry S, Hanisch FG, Leir SH, Sutton-Smith M, Morris HR, Dell A, Harris A. N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology. 2006;16:623-34.
17. Hull SR, Laine RA, Kaizu T, Rodriguez I, Carraway KL. Structures of the O-linked oligosaccharides of the major cell surface sialoglycoprotein of MAT-B1 and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma. J Biol Chem. 1984;259:4866-77.
18. Ho JJ, Cheng S, Kim YS. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids. Biochem Biophys Res Commun. 1995;210:866-73.
19. Carraway KL, Price-Schiavi SA, Komatsu M, Jepson S, Perez A, Carraway CA. Muc4/sialomucin complex in the mammary gland and breast cancer. J Mammary Gland Biol Neoplasia. 2001;6:323-37.
20. Saeland E, de Jong MA, Nabatov AA, Kalay H, Geijtenbeek TB, van Kooyk Y. MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol Immunol. 2009;46:2309-16.
21. Sakarya S, Gokturk C, Ozturk T, Ertugrul MB. Sialic acid is required for nonspecific adherence of Salmonella enterica ssp. enterica serovar Typhi on Caco-2 cells. FEMS Immunol Med Microbiol. 2010;58:330-5.
22. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4:45-60.
23. Galán JE. Molecular genetic bases of Salmonella entry into host cells. Mol Microbiol. 1996;20:263-71.
24. Zhao Q, Guo X, Nash GB, Stone PC, Hilkens J, Rhodes JM, Yu LG. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res. 2009;69:6799-806.
25. Senapati S, Chaturvedi P, Chaney WG, Chakraborty S, Gnanapragassam VS, Sasson AR, Batra SK. Novel INTeraction of MUC4 galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clin Cancer Res. 2011;17:267-74.
26. Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med. 2008;10:e17.
27. De Greve H, Wyns L, Bouckaert J. Combining sites of bacterial fimbriae. Curr Opin Struct Biol. 2007;17:506-12.
28. Giannasca KT, Giannasca PJ, Neutra MR. Adherence of Salmonella typhimurium to Caco-2 cells: identification of a glycoconjugate receptor. Infect Immun. 1996;64:135-45.
29. Hirai C, Ichiba H, SaitoM, Shintaku H, Yamano T, Kusuda S. Trophic effect ofmultiple growth factors in amniotic fluid or humanmilk on cultured human fetal small intestinal cells. J Pediatr Gastroenterol Nutr. 2002;34:524-8.
30. Mirpuri J, Brazil JC, Berardinelli AJ, Nasr TR, Cooper K, Schnoor M, Lin PW, Parkos CA, Louis NA. Commensal Escherichia coli reduces epithelial apoptosis through IFN-alphaA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine. J Immunol. 2010;184:7186-95.
31. Rudloff S, Kunz C. Protein and nonprotein nitrogen components in human milk, bovine milk, and infant formula: quantitative and qualitative aspects in infant nutrition. J Pediatr Gastroenterol Nutr. 1997;24:328-44.
32. Chichlowski M, German JB, Lebrilla CB, Mills DA. The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas. Annu Rev Food Sci Technol. 2011;2:331-51.
33. Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, Capretti R, Orazio G. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res. 2006;59:377-82.
34. Czirók E, Milch H, Nemeth K, Gado I. In vitro and in vivo (LD50) effects of human lactoferrin on bacteria. Acta Microbiol Hung. 1990; 37:55-71.
35. Stevens CR, Millar TM, Clinch JG, Kanczler JM, Bodamyali T, Blake DR. Antibacterial properties of xanthine oxidase in human milk. Lancet. 2000;356:829-30.